Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain
Abstract
Brain metastases are a common cause of disabling neurologic complications and death in patients with metastatic melanoma. Previous studies of nivolumab combined with ipilimumab in metastatic melanoma have excluded patients with untreated brain metastases. We evaluated the efficacy and safety of nivolumab plus ipilimumab in patients with melanoma who had untreated brain...
Paper Details
Title
Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain
Published Date
Aug 23, 2018
Volume
379
Issue
8
Pages
722 - 730
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History